NYSE: MANE · Life Sciences · 6 alerts · CIK 1827635
Share price
$128.05Close, Nov 16
Market cap
$5.4B
Shares outstanding
42.2MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834
Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Veradermics, Inc filings on SEC EDGAR ↗
Veradermics Director Patrick G. Enright Sells $75.2M of Stock
Patrick G. Enright, Director, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).
Veradermics 10% Owner Longitude Capital Partners V LLC Sells $75.2M of Stock
Longitude Capital Partners V LLC, 10% Owner, sold 500,000 shares of Veradermics, Inc at $150.38 a share, worth $75.2M in total on Nov 11, 2026. Shares held after the trade: 1,803,474 (-12.2%).
Veradermics, Inc. is a clinical-stage biopharmaceutical company focused on developing VDPHL01 for pattern hair loss. As of November 5, 2026, the company had 42,195,472 shares of common stock outstanding and continues to incur substantial losses with no products yet approved for commercial sale.